---
figid: PMC7948516__nihms-1624328-f0003
figlink: pmc/articles/PMC7948516/figure/F3/
number: F3
caption: 'a | Several pathways of brain energy metabolism in neurons are disrupted
  (shown with dashed black arrows) in neurodegenerative disorders of ageing (specific
  disorders with declines are shown in the red boxes). Increased production of reactive
  oxygen species (ROS) and neuroinflammation that negatively affect brain energy levels
  are shown with a thick black arrow. The combination of impaired ATP production and
  increased levels of ROS contributes to declining brain function. b | Molecules or
  potential therapies implicated in brain energy rescue strategies target six broad
  pathways: ATP and redox state (light blue); brain glucose transport and/or aerobic
  glycolysis (dark blue; interventions indicated with an asterisk: adiponectin, ghrelin,
  insulin (GLUT4 only), nicotinamide riboside, dichloroacetate, N-acetylcysteine,
  oxaloacetate, glucagon-like peptide 1 (GLP1), glucose-dependent insulinotropic polypeptide
  (GIP), leptin, amylin, metformin, liraglutide and sitagliptin); anaplerosis and
  the tricarboxylic acid (TCA) cycle (purple; propionic acid (C3), heptanoic acid
  (C7), octanoic acid (C8), d-β-hydroxybutyrate (BHB), and ketone esters (KE)); mitochondrial
  transport and biogenesis (olive-grey); ketogenesis (orange; interventions indicated
  with two asterisks: BHB, C8, decanoic acid (C10) and KE); or protection against
  ROS and inflammation (light green; interventions indicated with three asterisks:
  ghrelin, GLP1, GIP, leptin, adiponectin, metformin, AP39, mitochondrial division
  inhibitor 1 (mdivi-1), MitoQ, BHB, ketogenic diet and KE). Details of the molecules
  or potential therapies are shown in  (preclinical studies) and , (clinical studies).
  Complementary interventions such as caloric restriction, ketogenic diet and exercise
  are not shown. Neurons take up lactate generated by astrocytes and oligodendrocytes
  (not shown). Medium-chain fatty acids such as decanoic acid and octanoic acid in
  the circulation can enter astrocytes and produce ketones and acetyl coenzyme A (acetyl-CoA).
  AAV, adeno-associated virus; AcAc, acetoacetate; acetyl-CoA, acetyl coenzyme A;
  Ach, acetylcholine; AD, Alzheimer disease; AG, aerobic glycolysis; ALS, amyotrophic
  lateral sclerosis; ApoE4, E4 isoform of apolipoprotein E; ASO, antisense oligonucleotide;
  ATP Syn, ATP synthase; DA1, dynamin-related protein antagonist 1; ETC, electron
  transport chain; FTD, frontotemporal dementia; HD, Huntington disease; MCT, monocarboxylate
  transporter; mHTT, mutant huntington protein; NR, nicotinamide riboside; PD, Parkinson
  disease; PGC1α, peroxisome proliferator-activated receptor-γ coactivator 1α; PDH,
  pyruvate dehydrogenase; PPP, pentose phosphate pathway.'
pmcid: PMC7948516
papertitle: 'Brain energy rescue: an emerging therapeutic concept for neurodegenerative
  disorders of ageing.'
reftext: Stephen C. Cunnane, et al. Nat Rev Drug Discov. ;19(9):609-633.
pmc_ranked_result_index: '116816'
pathway_score: 0.9552826
filename: nihms-1624328-f0003.jpg
figtitle: 'Brain energy rescue: an emerging therapeutic concept for neurodegenerative
  disorders of ageing'
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7948516__nihms-1624328-f0003.html
  '@type': Dataset
  description: 'a | Several pathways of brain energy metabolism in neurons are disrupted
    (shown with dashed black arrows) in neurodegenerative disorders of ageing (specific
    disorders with declines are shown in the red boxes). Increased production of reactive
    oxygen species (ROS) and neuroinflammation that negatively affect brain energy
    levels are shown with a thick black arrow. The combination of impaired ATP production
    and increased levels of ROS contributes to declining brain function. b | Molecules
    or potential therapies implicated in brain energy rescue strategies target six
    broad pathways: ATP and redox state (light blue); brain glucose transport and/or
    aerobic glycolysis (dark blue; interventions indicated with an asterisk: adiponectin,
    ghrelin, insulin (GLUT4 only), nicotinamide riboside, dichloroacetate, N-acetylcysteine,
    oxaloacetate, glucagon-like peptide 1 (GLP1), glucose-dependent insulinotropic
    polypeptide (GIP), leptin, amylin, metformin, liraglutide and sitagliptin); anaplerosis
    and the tricarboxylic acid (TCA) cycle (purple; propionic acid (C3), heptanoic
    acid (C7), octanoic acid (C8), d-β-hydroxybutyrate (BHB), and ketone esters (KE));
    mitochondrial transport and biogenesis (olive-grey); ketogenesis (orange; interventions
    indicated with two asterisks: BHB, C8, decanoic acid (C10) and KE); or protection
    against ROS and inflammation (light green; interventions indicated with three
    asterisks: ghrelin, GLP1, GIP, leptin, adiponectin, metformin, AP39, mitochondrial
    division inhibitor 1 (mdivi-1), MitoQ, BHB, ketogenic diet and KE). Details of
    the molecules or potential therapies are shown in  (preclinical studies) and ,
    (clinical studies). Complementary interventions such as caloric restriction, ketogenic
    diet and exercise are not shown. Neurons take up lactate generated by astrocytes
    and oligodendrocytes (not shown). Medium-chain fatty acids such as decanoic acid
    and octanoic acid in the circulation can enter astrocytes and produce ketones
    and acetyl coenzyme A (acetyl-CoA). AAV, adeno-associated virus; AcAc, acetoacetate;
    acetyl-CoA, acetyl coenzyme A; Ach, acetylcholine; AD, Alzheimer disease; AG,
    aerobic glycolysis; ALS, amyotrophic lateral sclerosis; ApoE4, E4 isoform of apolipoprotein
    E; ASO, antisense oligonucleotide; ATP Syn, ATP synthase; DA1, dynamin-related
    protein antagonist 1; ETC, electron transport chain; FTD, frontotemporal dementia;
    HD, Huntington disease; MCT, monocarboxylate transporter; mHTT, mutant huntington
    protein; NR, nicotinamide riboside; PD, Parkinson disease; PGC1α, peroxisome proliferator-activated
    receptor-γ coactivator 1α; PDH, pyruvate dehydrogenase; PPP, pentose phosphate
    pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DLD
  - IGFALS
  - SLC2A4
  - SLC2A3
  - SLC2A1
  - DLAT
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - ACACA
  - TFCP2
  - C7
  - FGFR3
  - TPM2
  - SMN1
genes:
- word: (LAD,PD,HD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS,
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS,FTD)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: (LAD,PD,HD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS,
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS,FTD)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: GLUT1,3,4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: GLUT1,3,4
  symbol: GLUT3
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A3
  entrez: '6515'
- word: GLUT1,3,4
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: ↑GLUT1,3,4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: (LAD,PD,ALS)
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,PD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: HD,ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: (LAD)
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ACAC
  symbol: ACAC
  source: hgnc_prev_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: (LAD,PD,HD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS,
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS,FTD)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: CP2,KE,NR)
  symbol: CP2
  source: hgnc_alias_symbol
  hgnc_symbol: TFCP2
  entrez: '7024'
- word: CP2,
  symbol: CP2
  source: hgnc_alias_symbol
  hgnc_symbol: TFCP2
  entrez: '7024'
- word: (LAD,PD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: HD,ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: C7,
  symbol: C7
  source: hgnc_symbol
  hgnc_symbol: C7
  entrez: '730'
- word: (C8,C7,
  symbol: C7
  source: hgnc_symbol
  hgnc_symbol: C7
  entrez: '730'
- word: (LAD,PD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: HD,ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: CP2,(S)-equol)
  symbol: CP2
  source: hgnc_alias_symbol
  hgnc_symbol: TFCP2
  entrez: '7024'
- word: CP2,
  symbol: CP2
  source: hgnc_alias_symbol
  hgnc_symbol: TFCP2
  entrez: '7024'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: ↑GABA,Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: GABA,Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: (LAD)
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: transport(BHB,MitoQ,DA1
  symbol: DA1
  source: hgnc_alias_symbol
  hgnc_symbol: TPM2
  entrez: '7169'
- word: DA1
  symbol: DA1
  source: hgnc_alias_symbol
  hgnc_symbol: TPM2
  entrez: '7169'
- word: (LAD,PD,HD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: (LAD,
  symbol: LAD
  source: hgnc_prev_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: ALS)
  symbol: ALS
  source: hgnc_alias_symbol
  hgnc_symbol: IGFALS
  entrez: '3483'
- word: (small
  symbol: SMA2
  source: hgnc_alias_symbol
  hgnc_symbol: SMN1
  entrez: '6606'
chemicals: []
diseases: []
figid_alias: PMC7948516__F3
redirect_from: /figures/PMC7948516__F3
figtype: Figure
---
